A5008297202- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Lung Cancer Treatments and Mutations
- Hematopoietic Stem Cell Transplantation
- Cutaneous lymphoproliferative disorders research
- Medical Imaging Techniques and Applications
- Cancer Treatment and Pharmacology
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Blood groups and transfusion
- Monoclonal and Polyclonal Antibodies Research
- Erythrocyte Function and Pathophysiology
- Transplantation: Methods and Outcomes
- Genetic factors in colorectal cancer
- Lung Cancer Research Studies
- Cancer Genomics and Diagnostics
- Bone and Joint Diseases
- Neutropenia and Cancer Infections
- Hematological disorders and diagnostics
- RNA Interference and Gene Delivery
- Retinoids in leukemia and cellular processes
University Hospital Centre Zagreb
2013-2024
University of Zagreb
1993-2013
Klinički Bolnički Centar Rijeka
2006-2013
We investigated the association ofFcgammaRIIIaa and FcgRIIa polymorphisms response to R-CHOP in 58 patients with diffuse large B-cell lymphoma (DLBCL). FcgammaRIIIa did not influence response, event-free or overall survival. These results suggest that ADCC via FcgammaRIIa may be major mechanism of activity combination DLBCL.
The use of second-generation anticoagulants termed 'superwarfarins' as rodenticides, although widespread, is poorly controlled. Products containing superwarfarin have been marketed in over-the-counter rodenticides and can be easily purchased. Poor control potentiates the risk accidental or intentional poisoning, but clinicians may underestimate incidence toxicity. Therefore, when cases unexplained acquired coagulopathy selective deficiency vitamin K-dependent clotting factors occur patients...
AimTo evaluate the clinical utility of incorporating a novel heavy/light chain immunoassay (HLC) into existing methods for assessment multiple myeloma (MM) patients.MethodsConvenience sera samples from 90 previously treated IgG and IgA MM patients in different disease stages were analyzed. The study was conducted Clinical Hospital Center Zagreb between 2011 2013. collected analyzed by standard laboratory techniques (serum protein electrophoresis, quantification total immunoglobulins, serum...
Background: Patients with refractory Hodgkin's disease or relapsing after high-dose therapy and autografting have a poor prognosis. Here, we present our experiences gemcitabine in this setting. Methods: We treated 14 patients relapsed gemcitabine. The treatment was given on compassionate use basis, off-label not according to study protocol. were 17-46 years of age. 1 patient had stage IA disease, 2 IIIB 11 IVB disease. 9 received radiotherapy. 8 been autografted auto- allografted....
The paper describes our results in treatment of Burkitt lymphoma / leukemia with rituximab and high-dose methotrexate based chemotherapy.
Escalated BEACOPP (eBEACOPP) is an effective but fairly toxic regimen for the treatment of Hodgkin lymphoma (HL). Avascular necrosis (AVN) femoral head was previously reported to increase in patients treated with eBEACOPP, so far, no systematic analysis its frequency has been published.To analyse and identify possible risk factors AVN development eBEACOPP.We identified 26 eBEACOPP newly diagnosed high-risk advanced-stage HL, 25 whom were alive at time study. All invited participate a...
To correlate the numbers of silver staining nuclear organiser regions (AgNORs) in non-Hodgkin's lymphoma classified by working formulation with survival, first complete remission, and length remission.Sixty one patients were included study. Paraffin wax sections stained using solution to visualise nucleolar regions. The AgNORs counted 150 nuclei each specimen. Data examined Kruskal-Wallis test, multivariate discriminant analysis, Cox's regression test. Curves calculated method Kaplan...
Background.The aim of the study was to asses negative predictive value (NPV) FDG-PET performed with triple-head coincidence gamma camera after first-line therapy or salvage in patients Hodgkin's disease (HD) compared by a long-term follow-up as reference standard.Methods.This retrospective diagnostic test done at University Hospital Centre Zagreb between June 2001 and February 2008.The charts 131 consecutive were reviewed.Seventy-three PET-negative (median age 28 years; range 12-80 years)...